HCC Clinical Trials in Shanghai, Shanghai Municipality
21 recruitingShanghai, Shanghai Municipality, China
Showing 1–20 of 21 trials
Recruiting
Phase 2
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma
Hepato Cellular Carcinoma (HCC)
Fudan University350 enrolled1 locationNCT07328009
Recruiting
Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment
Advanced Hepatocellular Carcinoma (HCC)
Fudan University150 enrolled1 locationNCT07147101
Recruiting
Phase 2
HAIC Combined With Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03)
Hepatocellular Carcinoma (HCC)
Fudan University164 enrolled1 locationNCT06860490
Recruiting
Phase 2
A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC
HCC - Hepatocellular Carcinoma
TaiRx, Inc.40 enrolled1 locationNCT07521852
Recruiting
Phase 2Phase 3
A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment.
Hepatocellular Carcinoma (HCC)
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.680 enrolled2 locationsNCT07490262
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Hepatocellular Carcinoma (HCC)
Bristol-Myers Squibb129 enrolled46 locationsNCT07291076
Recruiting
Phase 2
Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)
Hepatocellular Carcinoma (HCC)
Ruijin Hospital35 enrolled4 locationsNCT07331883
Recruiting
Phase 2
Phase 2 Study of WGI-0301 for Advanced HCC
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang Haichang Biotech Co., Ltd.60 enrolled4 locationsNCT06309485
Recruiting
Phase 1
IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma
HCC
Shanghai Zhongshan Hospital18 enrolled1 locationNCT06757881
Recruiting
Phase 2
ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
Hepatocellular Carcinoma (HCC)
Abbisko Therapeutics Co, Ltd141 enrolled51 locationsNCT07327034
Recruiting
Phase 2Phase 3
The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD
HCC - Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital20 enrolled1 locationNCT07285850
Recruiting
Phase 2
Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab
Hepatocellular Carcinoma (HCC)
Fudan University141 enrolled1 locationNCT07100392
Recruiting
Phase 2
Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab
Hepatocellular Carcinoma (HCC)
Fudan University146 enrolled1 locationNCT07047586
Recruiting
Phase 2
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
RadiotherapyHCC - Hepatocellular Carcinoma
Shanghai Zhongshan Hospital35 enrolled1 locationNCT06870942
Recruiting
Phase 1
A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma (HCC)
AbbVie20 enrolled11 locationsNCT06487559
Recruiting
Phase 2
HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence
Hepato Cellular Carcinoma (HCC)
Fudan University165 enrolled3 locationsNCT06812039
Recruiting
Phase 1
A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors
Advanced Solid TumorsHCC
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.108 enrolled1 locationNCT06764836
Recruiting
The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
Hepatocellular Carcinoma (HCC)
Ruijin Hospital40 enrolled1 locationNCT06746194
Recruiting
Early Phase 1
Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine12 enrolled1 locationNCT06652243
Recruiting
Phase 1
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
Hepatocellular CarcinomaHCCHepatitis B Virus Related Hepatocellular Carcinoma
SCG Cell Therapy Pte. Ltd.38 enrolled7 locationsNCT06617000